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ABSTRACT
Ascorbic acid has two isoforms, i.e., L-ascorbic acid which exists naturally and D-ascorbic acid which only can be 
found in synthetic form. This study aimed to determine the cytotoxic effect of L- and D- ascorbic acid on primary cell, 
i.e. murine and human suspension cells of peripheral blood. Murine and human suspension blood cells were obtained 
through density gradient centrifugation using Ficoll-Paque™ PLUS. Non-adherent cells were identified after 7 days in 
culture and seeded at 1 × 105 cells/mL. Both newly isolated primary cells were analyzed for in vitro proliferation ability 
for 7 days. The cells were treated with L- and D-ascorbic acid at concentrations 30, 50, and 90 µg/mL followed by 
Trypan blue viability assay at day 0, 3, 7, and 14. Cells cultured in the complete medium were represented as control. 
Murine and human suspension blood cells showed round morphology and significant increase of viable cells after 7 
days in complete medium. Both cells treated with L-ascorbic acid exhibited low cytotoxic effect at 30, 50, and 90 µg/mL 
concentrations. In addition, murine blood cells treated with D-ascorbic acid caused total population cell death in all 
three concentrations at day 14, whereas human suspension blood cells only exhibited total population cell death at 
higher concentration, i.e. 90 µg/mL. In conclusion, L-ascorbic acid exhibited minimal cytotoxic effect on both primary 
cell sources as compared to lethal effect of D-ascorbic acid treatment. 
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ABSTRAK
Asid askorbik terdiri daripada dua isoform iaitu L-asid askorbik yang wujud secara semula jadi dan D-asid askorbik 
yang hanya terdapat dalam bentuk sintetik. Kajian ini adalah bertujuan untuk menentukan kesan sitotoksik L- dan 
D-asid askorbik ke atas sel primari iaitu sel ampaian darah periferi mencit dan manusia. Sel ampaian darah mencit 
dan manusia diperoleh melalui kaedah pengemparan kecerunan ketumpatan menggunakan Ficoll-Paque™ PLUS. Sel 
ampaian dikenal pasti selepas 7 hari pengkulturan dan dikulturkan pada ketumpatan 1 × 105 sel/mL. Kedua-dua 
sumber sel yang baru dikulturkan dianalisis bagi menentukan keupayaan proliferasi in vitro selama 7 hari. Sel 
seterusnya dirawat dalam L- dan D-asid askorbik pada kepekatan 30, 50 dan 90 µg/mL diikuti dengan pengasaian 
keviabelan tripan biru pada hari 0, 3, 7 dan 14. Sel yang dikulturkan dalam medium lengkap mewakili kawalan. Sel 
ampaian darah mencit dan manusia menunjukkan morfologi bulat dan sel viabel didapati meningkat secara signifikan 
selepas 7 hari di dalam medium lengkap. Kedua-dua sel yang dirawat dengan L-asid askorbik menunjukkan kesan 
sitotoksik yang rendah pada kepekatan 30, 50 dan 90 µg/mL. Walau bagaimanapun, sel yang dirawat dengan D-asid 
askorbik menyebabkan kematian sel pada ketiga-tiga kepekatan pada hari ke-14, manakala sel ampaian manusia hanya 
menunjukkan kematian keseluruhan sel pada kepekatan tinggi iaitu 90 µg/mL.  Kesimpulannya, L-asid askorbik 
menunjukkan kesan sitotoksik yang minima ke atas kedua-dua sumber sel primari berbanding kesan kematian dalam 
rawatan D-asid askorbik.
Kata kunci: D-asid askorbik; L-asid askorbik; Mus musculus; sel ampaian darah manusia; sitotoksisiti
INTRODUCTION
Ascorbic acid is a crucial element for metabolic function 
in living organisms. It is commonly known as Vitamin C 
or L-ascorbic acid and exists in nature. Meanwhile, another 
enantiomer known as D-ascorbic acid does not exist in 
nature and has to be synthesized (Naidu 2003; Pham-Huy 
et al. 2008). Many studies that have been conducted solely 
focused on the effects of L-ascorbic acid instead of 
D-ascorbic acid towards mammalian cells (Choi et al. 
2008; Esteban et al. 2010; Kawada et al. 2013). Comparison 
between chemical structure of D-ascorbic acid and 
L-ascorbic acid showed a minor difference in the position 
of hydrogen atom that could cause a difference in 
cytotoxicity potential (Figure 1). Currently there is no study 
involved in determining the toxic effect of L-ascorbic acid 
versus D-ascorbic acid isoforms in primary mammalian 
suspension cells. 
L-ascorbic acid is an antiscorbutic agent that assists 
wound and fracture healing via synthesis of collagen for 
skin and bone (Canty & Kadler 2005; Qiao et al. 2009). 
Antiscorbutic potential refers to the ability of an agent in 
preventing or curing scurvy disease. L-ascorbic acid also 
displays antioxidant properties which scavenge the free 
radicals, thus decelerate cell aging, protect the cell 
components from oxidative damage and kill the tumour 
cells. Unfortunately, it cannot be synthesized by human 
body due to the lack of L-gulono-γ-lactone oxidase enzyme 
as compared to mice which is able to produce endogenous 
vitamin C. Therefore, human are solely dependent on an 
exogenous source of Vitamin C through their diet intake 
(Du et al. 2012; Pham-Huy et al. 2008; Yokoo et al. 2004). 
On the other hand, D-ascorbic acid displays only 2.5-5 % 
of antiscorbutic potential with no known significant 
biological role (Leung et al. 1993). However, the 
synthesized D-ascorbic acid was commonly used as food 
antioxidant in food industries especially to prevent the 
oxidation of meat and protect the colour in food. 
Peripheral blood has been an excellent source of adult 
stem cells with advantages such as easily accessible and 
no ethical conflict. Previous studies have demonstrated 
that the stem cells from peripheral blood can be divided 
into two types; adherent and suspension blood stem cells. 
The adherent cells were characterized as mesenchymal 
stem cells, while the suspension cells were characterized 
as HSCs. This characterization was performed on both 
murine and human source of peripheral blood stem cells. 
The suspension blood stem cells were obtained using a 
combination of gradient centrifugation and culture 
selection (Ab Kadir et al. 2012; Ariffin et al. 2010; Hadzir 
et al. 2014; Yazid et al. 2011; Yuan et al. 2019). However, 
in this study, both isolated cell types were categorized as 
a population of primary mammalian suspension cells.
Various studies have demonstrated that supplementation 
of ascorbic acid with an appropriate dose in culture medium 
produced significant effect on stem cell generation, 
proliferation and differentiation (Ayu Suraya et al. 2018; 
Zhang et al. 2016). Stem cell transplantation was conducted 
with the aid of scaffold. The scaffolds were built using 
various biomaterials and act as a mechanical cue for in 
vitro culture and differentiation (Busra et al. 2018; Hanis 
et al. 2018; Shamsul et al. 2018, 2013; Shanmuganantha 
et al. 2018). L-ascorbic acid alone without the addition of 
other differentiation factors was found able to differentiate 
human suspension blood stem cells into osteoblasts (Hadzir 
et al. 2014). Other studies also looked into the potential of 
L-ascorbic acid derivatives as osteoblasts differentiation 
inducer on human bone marrow mesenchymal stem cells 
(BMMSC) and periodontal ligament (PDL) cells (Choi et 
al. 2008; Ishikawa et al. 2004). L-ascorbic acid was also 
found able to induce proliferation of mesenchymal stem 
cells derived from adipose tissue (AT-MSC) (Potdar & 
D’Souza 2010). However, the level of cellular toxicity for 
both L- and D-ascorbic acid in primary primitive cells such 
as HSCs is still unknown. Hence, this study was conducted 
to elucidate the toxic effect of both L- and D-ascorbic acid 
isoforms on primary murine and human suspension blood 
cells. 
MATERIALS AND METHODS
ETHICAL APPROVAL AND SAMPLE COLLECTION
Prior to blood sample collection, the ethical guidelines 
have been approved by the Research Ethics Committee 
(Approval number: UKM 1.5.3.5/244/02-01-02-SF1052) 
and Animal Ethics Committee (Approval number: 
FST/2015/SHAHRUL/25-MAR./664-MAR.-2015-FEB.-
2018-AR-CAT2) of Universiti Kebangsaan Malaysia. The 
blood sample from healthy human volunteers (18-25 years 
old) was obtained via venipuncture with informed consent. 
On the other hand, the blood sample from ICR strain mice 
(Mus musculus) (4-6 weeks old) was obtained through 
cardiac puncture.
MURINE AND HUMAN PERIPHERAL BLOOD PRIMARY 
SUSPENSION CELLS ISOLATION
The blood sample from both murine and human were 
drawn into the ethylenediamine tetraacetic acid (EDTA) 
tubes (BD, Franklin Lakes, NJ, USA) and diluted with 
 
FIGURE 1. Chemical structure of L- and D-ascorbic acid. Wedged line (red arrow) indicates 
the position of the bond and the atom to the front. Dashed line (blue arrow) indicates the 
position of the bond and the atom to the back. Structures were drawn using ChemDraw JS 
online software (https://chemdrawdirect.perkinelmer.cloud/js/sample/index.html#) 
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phosphate buffer saline (PBS) (pH 7.4; Gibco, Grand 
Island, NY, USA). The diluted blood was layered on top 
of the Ficoll-Paque™ PLUS (GE Healthcare, Pittsburgh, 
PA, USA) and centrifuged at 400 g for 30 min at room 
temperature. After centrifugation, cells at the buffy coat 
layer were collected and washed with PBS thrice. The 
blood cells were cultured in proliferation medium 
containing α-minimal essential medium (Gibco, Grand 
Island, NY, USA) supplemented with 10% (v/v) newborn 
calf serum (Gibco, Grand Island, NY, USA) and 2% (v/v) 
penicillin-streptomycin (Sigma, USA). After 7 days of 
culture in incubator containing 5 % of CO2 at 37 °C, the 
non-adherent blood cells which can be distinguished as 
cells with round morphology were suspended in the 
complete medium. The suspension blood cells cultured in 
complete medium until day 7 were used for further cellular 
analysis.   
CELL PROLIFERATION ANALYSIS
The suspension blood cells were distinguished and isolated 
from the culture after 7 days and used for proliferation 
analysis. The cells were seeded at 1 × 105 cells/mL in 
proliferation medium and counted using trypan blue 
exclusion assay every day for 7 days. The cells were 
incubated at 37 °C with 5 % CO2 and the medium was 
changed for every 3 days. The day of seeding is considered 
as day 0. 
CELL SEEDING AND ASCORBIC ACID TREATMENT
The suspension blood cells were seeded at 1 × 105 cells/
mL for cytotoxicity study using the 24 well plates. The 
cells cultured in proliferation medium were added with 
either L- or D-ascorbic acid (Sigma Aldrich, USA) at 
concentrations of 30, 50, and 90 µg/mL, respectively. The 
cells in proliferation medium (normal medium without 
ascorbic acid) acted as control (complete medium). The 
suspension blood cells were incubated at 37 °C with 5 % 
CO2 and the medium was changed every 3 days. Viability 
analysis was performed at day 0, 3, 7, and 14 in the 
presence of various concentrations of ascorbic acid (The 
day of ascorbic acid treatment started was considered as 
day 0). Murine and human suspension blood cells were 
tested separately.
TRYPAN BLUE EXCLUSION ASSAY
Viability analysis was determined using trypan blue 
exclusion assay and conducted at day 0, 3, 7, and 14. A 
total of 10 µL of suspension peripheral blood cells were 
mixed with 10 µL of 0.4 % trypan blue solution (Life 
Technologies, Grand Island, NY, USA). The cells stained 
in blue colour were dead cells and the cells with halo-like 
and colourless appearance were viable cells. The number 
of viable cells was determined using haemocytometer and 
mean±standard deviation was given for three biological 
replicates (n=3) where each biological replicate consists 
of three readings.
STATISTICAL ANALYSIS
Statistical analysis was performed using Student’s t-test 
where p<0.05 was considered as statistically significant. 
RESULTS AND DISCUSSION
ISOLATION AND MORPHOLOGY OF PRIMARY 
SUSPENSION BLOOD CELLS
The cell morphology of murine and human primary 
suspension blood cells was observed under an inverted 
microscope. As shown in Figure 2(A) and 2(B), the 
suspension blood cells of both murine and human origins 
indicated a round morphology with halo-like appearance. 
In this study, the murine and human suspension blood cells 
were cultured in the presence of complete medium for 7 
days before both cells were tested separately with L- and 
D-ascorbic acid isoforms. This allows a successful isolation 
of murine and human suspension blood cells after density 
gradient centrifugation and a seven-day culture selection 
approach. During this time frame, culture selection takes 
place where fully differentiated and mature cell population 
and other precursor cells would die due to limited shelf 
life (Ariffin et al. 2010; Hadzir et al. 2014; Yazid et al. 
2011; Yuan et al. 2019). 
IN VITRO POPULATION OF MURINE AND HUMAN 
SUSPENSION BLOOD CELLS
Trypan blue is one of the common dye exclusion assay 
used to determine the number of viable cells present in cell 
suspension (Strober 2001). As a membrane selective dye, 
trypan blue dye can penetrate the cell membrane and 
indicate the dead or non-viable cells in blue colour whereas 
viable cells appear colourless due to intact and non-
permeable cell membrane (Strober 2001; Tran et al. 2011). 
Previous studies have shown that the viability of suspension 
cell can be analysed using trypan blue exclusion method 
(Ariffin et al. 2010; Hadzir et al. 2014; Shahrul Hisham et 
al. 2016; Strober 2001). The use of trypan blue is not only 
limited to suspension cells but can also be used to assess 
the viability of adherent cells (Ravinanthanan et al. 2018; 
Wan Haifa Haryani et al. 2010). Trypan blue exclusion 
method can determine the cell survival ability post 
isolation, i.e. from in vivo to in vitro microenvironment 
and cell proliferation during in vitro culture (Intan Zarina 
et al. 2010). Peripheral blood cells used in this study are 
in suspension form, therefore trypan blue exclusion assay 
was chosen instead of MTT assay.
Proliferation analysis of murine suspension blood cells 
showed a significant increase (p<0.05) in the number of 
viable cells from day 1 onwards as compared to day 0 
(Figure 3(A)). Meanwhile, Figure 3(B) exhibited 
proliferation analysis of human suspension blood cells 
which also indicated a significant increase (p<0.05) in the 
number of viable cells starting from day 2 until 7 as 
compared to day 0. Proliferation analyses showed that both 
cells are highly viable and capable of self-renewal. Since 
both cells possess in vitro proliferative ability, any 
cytotoxic effect from ascorbic acid isoforms would 
drastically inhibit the cell growth or may cause cell death. 
A significant increase (p<0.05) in the viable cells for both 
cell types indicated that the suspension blood cells have 
self-replicative ability. High expansion potential of HSCs 
has been published by multiple researchers (Ab Kadir et 
al. 2012, 2011; Ariffin et al. 2010; Intan Zarina et al. 2010). 
Proliferation ability is not only important during cell 
growth but is also tightly regulated during differentiation 
mechanism (Lange & Calegari 2010).
CYTOTOXIC EFFECTS OF L-ASCORBIC ACID AND 
D-ASCORBIC ACID ISOFORMS
In this study, we would like to determine the effect of two 
different ascorbic acid isoforms on murine and human 
suspension blood cells. Two isoforms of ascorbic acid 
which are L-ascorbic acid and D-ascorbic acid were used. 
L-ascorbic acid is widely used for cell culture studies due 
to its beneficial properties and was also extensively used 
in osteoblasts differentiation upon many sources of cells 
(Gorrini et al. 2013; Graneli et al. 2014; Kermani et al. 
2014; Kim et al. 2012; Kyllonen et al. 2013; Maroon et al. 
2010; Montecinos et al. 2007; Rohaya et al. 2017; Shahrul 
Hisham et al. 2017). Its role in the bone formation in human 
body was well-established where proline and lysine 
hydroxylation is dependent on ascorbic acid as cofactor 
which eventually forms collagen Type I. This particular 
type of collagen is abundant in bone, approximately more 
than 95% (Murad et al. 1981; Yamauchi & Sricholpech 
2012). 
As for D-ascorbic acid, no prior studies were 
conducted on cell lines or primary cell cultures. Most of 
the in vitro osteoblast differentiation studies used 
L-ascorbic acid at the concentration of 50 µg/mL along 
with other differentiation factors (Farinawati et al. 2019, 
2018; Kawaguchi et al. 1999; Nam et al. 2011; Tran Hle 
et al. 2015). In this study, we also observed the effect of 
ascorbic acid using three concentrations, i.e. 30, 50, and 
90 µg/mL. It was found that proliferation or differentiation 
of MSC were dependent on ascorbic acid concentration 
(Choi et al. 2008). Therefore, the concentrations of 30, and 
90 µg/mL were chosen to represent a lower and higher 
concentration than 50 µg/mL.
Cytotoxic effect of L- and D- ascorbic acid isoforms toward 
murine suspension blood cells
The effect of L-ascorbic acid at 30, 50, and 90 µg/mL 
concentrations on murine suspension cells for 14 days is 
shown in Figure 4(A). Day 0 for all treatments were 
FIGURE 2. Morphology of (A) murine and (B) human suspension blood stem cells after 7 days of isolation before cytotoxicity test. 
Viable cells exhibited round and halo-like appearance (arrow). Magnification: 100X
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FIGURE 3. Proliferation of isolated murine and human suspension blood stem cells cultured in complete 
medium for 7 days. Mean±standard error of mean was given from three biological replicates (n=3).                                                                    
*statistical significance (p<0.05) as compared to day 0
represented as 105 viable cells. Control cells that was 
cultured in complete medium proliferated normally, thus 
exhibited a significant increase (p>0.05) in the number of 
viable cells when compared to day 0. However, L-ascorbic 
acid treatment on the murine suspension blood cells treated 
until day 14 showed no significant changes (p>0.05) in 
viable cell number as compared to the cells at day 0. 
Although the concentrations of L-ascorbic acid and 
incubation days were increased, the number of viable cells 
still remained similar throughout treatment (Figure 4(A)). 
This is an indication that L-ascorbic acid concentrations 
produced cellular survival signals by maintaining the 
number of viable cells throughout 14 days of exposure.
Figure 4(B) represents the murine suspension blood 
cells treated with 30, 50, and 90 µg/mL D-ascorbic acid 
for 14 days. At day 0, all treatments were represented as 
105 viable cells. Contrast with L-ascorbic acid, D-ascorbic 
acid treatment indicated significant decrease (p<0.05) in 
the number of viable cells at day 3 and 7 as compared to 
day 0 and total cell death at day 14. This also indicated 
that when incubation days were increased, the number of 
viable cells in all tested D-ascorbic acid concentrations 
were decreased (p<0.05) as compared to the cells cultured 
from previous day. In contrast, for control (complete 
medium), the cells indicated a significant increase (p<0.05) 
in the number of viable cells when cultured at day 3, 7, 
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FIGURE 4. Effect of (A) L- and (B) D-ascorbic acid on proliferation of murine suspension 
blood cells. Mean±standard error of mean was given from three biological replicates (n=3).  
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FIGURE 4. Effect of (A) L- and (B) D-ascorbic acid on proliferation of urine suspension 
blood cells. Mean±standard error of mean was given from three biological replicates (n=3).  
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FIGURE 4. Effect of (A) L- and (B) D-ascorbic acid on proliferation of murine suspension blood cells. Mean±standard error of 
mean was given from three biological replicates (n=3). L-ascorbic acid had no significant cytotoxic effect on murine suspension 
blood stem cells. D-ascorbic acid showed lethal effect on cells at day 14; *p<0.05
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and 14 as compared to day 0 (Figure 4(B)). Although not 
many studies on cytotoxicity of L-ascorbic acid upon 
murine cells or cells were performed, this isoform was 
introduced on mice induced pluripotent stem cells (iPSC) 
at the concentration of 25 or 50 µg/mL. L-ascorbic acid 
was found able to enhance iPSC generation and can convert 
pre-iPSC to iPSC so that the cells can achieve a pluripotent 
state. The addition of L-ascorbic acid also elongated the 
lifespan of iPSC by increasing its proliferation potential 
thus, bypassed the cell senescence (Esteban et al. 2010). 
However, murine cell sources indicated a decrease in cell 
viability as the concentration of L-ascorbic acid increased. 
This showed that an optimum concentration of L-ascorbic 
acid is needed to induce proliferation of murine cells 
without killing them. The murine osteoblasts precursor, 
i.e., MC3T3-E1 cell line was previously tested with 
L-ascorbic acid. It showed a significant increase in the ALP 
production and the formation of osteoblasts which was 
determined via von Kossa staining protocol (Intan Zarina 
et al. 2018; Shiga et al. 2003). From these studies, we can 
postulate that L-ascorbic acid could induce differentiation 
of MC3T3-E1 cells using proper concentration. In our 
study, the number of murine suspension blood cells treated 
with 30-90 µg/mL of D-ascorbic acid were found to be 
decreased significantly until total population cell death was 
observed at day 14 (Figure 4(B)). This indicated that 
D-ascorbic acid isoform can cause lethal toxicity effect on 
murine suspension blood cells after 14 days of treatment.
Human suspension blood cells cytotoxic effect of L- and 
D- ascorbic acid isoforms
Human suspension blood cells were also cultured in 
different ascorbic acid isoforms (L- and D-) at three 
different concentrations, i.e., 30, 50, and 90 µg/mL. Figure 
5(A) shows the effect of 30, 50, and 90 µg/mL of L-ascorbic 
acid on human suspension blood cells cultured for 14 days. 
The cell number at day 0 for all treatments was represented 
as 105 viable cells. Based on Figure 5(A), control cells 
cultured in complete medium showed a significant increase 
(p<0.05) in viable cell numbers throughout 14 days of 
culture with the highest viable cells at approximately 2.5 
× 106 cells. During L-ascorbic acid treatment, the number 
of viable cells for all concentrations showed a significant 
decrease (p<0.05) as compared to day 0 (Figure 5(A)). 
Although a significant reduction of cell viability at all 
concentrations was observed, the human suspension blood 
cells still exhibited the presence of viable cells at all three 
concentrations until 14 days of exposure (Figure 5(A)). 
Meanwhile, the viability profile of the human 
suspension blood cells exposed with 30, 50, and 90 µg/mL 
D-ascorbic acid for 14 days was also displayed in Figure 
5(B). D-ascorbic acid treatment showed a significant 
decrease (p<0.05) in the number of viable cells as 
compared to day 0 (Figure 5(B); 30, 50, and 90 µg/mL). 
The number of viable cells had decreased gradually when 
the incubation days were increased in all three 
concentrations. In addition, no viable cells were observed 
in the presence of 90 µg/mL of D-ascorbic acid for 14 days, 
i.e. cells experienced complete cell death in this 
concentration. 
Previously, a study on the breast cancer and normal 
cell lines treated with 0.1-1.0 mM of L-ascorbic acid found 
that the normal cell lines survived while the cancer cell 
lines underwent cell death. Similarly, the human leukemic 
cell lines which were treated with 0.28-2.80 mM of 
L-ascorbic acid for an hour had indicated apoptosis, while 
the normal hematopoietic stem cells or progenitor cells 
survived. These studies showed that L-ascorbic acid has 
anticancer properties that selectively kills the cancer cells 
at a low concentration in contrast with the normal cells 
and stem cells that exhibited the presence of viable cells 
(Kawada et al. 2013).
In addition, a study on the BMMSC reported that 
L-ascorbate-2-phosphate enhanced cell proliferation 
(initial seeding density of 104 cells/well) tremendously 
with increased ascorbic acid concentrations (5-250 mM). 
However, the addition of 0.5 mM of ascorbic acid reduced 
the cell viability which occurred probably due to the 
induction of cell death (Choi et al. 2008). Comparative to 
this study, human and murine suspension blood stem cells 
produce approximately similar or lower number of viable 
cells, respectively at 0.17-0.51 mM of L-ascorbic acid 
(equivalent to 30-90 µg/mL).
Comparison between murine and human suspension cells 
exposed with L- and D-ascorbic acid isoforms
In the human suspension blood cells, the cells survived 
better in L-ascorbic acid as compared to D-ascorbic acid 
treatment during the culture period. On the other hand, the 
murine suspension blood cells also survived well for 14 
days in L-ascorbic acid treatment. However, both cells 
exhibited a decrease in the number of viable cells when 
exposed to D-ascorbic acid. It is implicated that D-ascorbic 
acid is unsuitable for both murine and human suspension 
blood cells. In contrast, L-ascorbic acid at all concentrations 
(30, 50, and 90 µg/mL) did not cause much detrimental 
effect on both murine and human suspension cells. 
The effect of 30, 50, and 90 µg/mL for both isoforms 
on murine and human suspension blood cells at day 7 and 
14 were compared (Figure 6). For L-ascorbic acid on the 
murine suspension blood primary cells, all L-ascorbic acid 
concentrations indicated that the cell survival were 
maintained at approximately 95% at both day 7 and 14. 
Similarly, when the human suspension blood cells were 
incubated in L-ascorbic acid, the percentage of cell survival 
were slightly decreased to a certain extent approximately 
90% for all three L-ascorbic acid concentrations at day 7 
and 14. 
While for D-ascorbic acid at day 7, both murine and 
human blood cells showed a significant reduction in the 
percentage of viable cells (p<0.05) when treated with 
D-ascorbic acid as compared to L-ascorbic acid which 
were below 80%. Furthermore, treatment of murine 
suspension cells at day 14 with D-ascorbic acid displayed 
no viable cells at all three concentrations, hence it exhibited 
a lethal effect to the murine suspension cells. On the other 
hand, the human suspension blood cells demonstrated 
lethal effect only in 90 µg/mL of D-ascorbic acid treatment 
at day 14 (Figure 5), i.e. a total population of cell death in 
this condition. However, 30 and 50 µg/mL of D-ascorbic 
acid treatments only showed toxic effects towards human 
suspension blood cells. This is proven by a significant 
decrease (p<0.05) in the percentage of viable cells (<65%) 
which can be observed for both 30 and 50 µg/mL of 
D-ascorbic acid treatment at day 14 (Figure 6). This is an 
indication that D-ascorbic acid exhibited higher cytotoxic 
effect towards murine cells as compared to the human cells. 
Therefore, L- ascorbic acid maintained the survival for 
both murine and human suspension blood cells. In contrast, 
D-ascorbic acid showed lethal effect to the murine 
suspension blood cells and exhibited toxic effects upon 
human suspension blood cells with lethal effect only shown 
at 90 µg/mL after exposure for 14 days. 
During in vitro cell culture, L-ascorbic acid has shown 
better proliferation potential at concentration below 50 µg/
mL with similar potential in the normal cell lines (Esteban 
et al. 2010). However, treatment of L-ascorbic acid in 
cancer cells showed cell death when concentration as low 
as 15 µg/mL was utilized (Kawada et al. 2013). This 
indicates that L-ascorbic acid can selectively kill cancerous 
cells without harming the normal cells. Meanwhile, 
D-ascorbic acid may lack such selectiveness since it kills 
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both normal and cancer cells at concentration above 100 
µg/mL (Miura et al. 2015). This is probably the reason 
behind cell death observed during D-ascorbic acid 
treatment on both murine and human suspension blood 
cells at day 14. 
CONCLUSION
Murine and human source of suspension blood cells 
display almost similar results due to their genetic 
similarity. Both cell types showed the ability to survive 
in the presence of L-ascorbic acid. In contrast, D-ascorbic 
acid was found to exhibit lethal effect on the murine blood 
cells, whereas exhibited cytotoxic effect on the human 
blood cells with lethal effect only showed at 90 µg/mL 
after 14 days of exposure. This indicated that the natural 
L-ascorbic acid is a better option for both in vitro and in 
vivo studies in mammalian compared to the synthetic 
D-ascorbic acid where the concentration used should not 
exceed 90 µg/mL. The knowledge gained from this study 
can be further used to study the effect of L-ascorbic acid 
alone on in vitro primary cells and cell lines as well as in 
vivo model. 
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